Search Results Search Sort by RelevanceMost Recent Letter to the Editor Jul 2020 Response to “A Deliberate Public Policy Plus Naivety at Best” Stella Aguinaga Bialous, DrPH and Yvette van der Eijk, PhD Debate continues on how to frame tobacco and nicotine product regulation from a children’s rights perspective. AMA J Ethics. 2020;22(7):E643-644. doi: 10.1001/amajethics.2020.643. State of the Art and Science Apr 2016 Keeping the Backdoor to Eugenics Ajar?: Disability and the Future of Prenatal Screening Gareth M. Thomas, PhD and Barbara Katz Rothman, PhD Noninvasive prenatal testing arguably constitutes a form of eugenics in a social context in which certain reproductive outcomes are not valued. AMA J Ethics. 2016;18(4):406-415. doi: 10.1001/journalofethics.2016.18.4.stas1-1604. Case and Commentary Feb 2022 ¿Cómo deben los médicos determinar la disposición de un paciente traumatizado para regresar al trabajo? Tabitha E. H. Moses, MS and Arash Javanbakht, MD AMA J Ethics. 2022;E111-119. doi: 10.1001/amajethics.2022.111. Case and Commentary Feb 2022 ¿Debería un médico alguna vez violar los protocolos SWAT o TEMS durante un incidente con múltiples víctimas? Brandon Morshedi, MD, DPT and Faroukh Mehkri, DO AMA J Ethics. 2022;E120-125. doi: 10.1001/amajethics.2022.120. Policy Forum Feb 2022 ¿Cómo deberían los clínicos tácticos ayudar a hacer un uso más justo de la fuerza? David Callaway, MD and Faroukh Mehkri, DO AMA J Ethics. 2022;E133-139. doi: 10.1001/amajethics.2022.133. Policy Forum Feb 2022 ¿Cómo se debería equilibrar el riesgo para el personal táctico con los requerimientos clínicos y ética de rescate? Mollie V. Williams, MD, MPH and Olaitan Ajisafe, MD, PharmD AMA J Ethics. 2022;E140-144. doi: 10.1001/amajethics.2022.140. Podcast Feb 2022 Author Interview: “How Should Clinicians Determine a Traumatized Patient’s Readiness to Return to Work?” Tabitha E. H. Moses, MS joins Ethics Talk to discuss her article, coauthored with Dr Arash Javanbakht: “How Should Clinicians Determine a Traumatized Patient’s Readiness to Return to Work?” Case and Commentary May 2022 Should Clinicians Prescribe Non-FDA Regulated Dietary Supplements When Caring for Children With Hypovitaminosis D? Ethan A. Mezoff, MD, Hannah Hays, MD, and Ala Shaikhkhalil, MD Children with micronutrient deficiency might need supplementation, sometimes in irregularly high doses. AMA J Ethics. 2022;24(5):E353-360. doi: 10.1001/amajethics.2022.353. Case and Commentary May 2022 How Does Cognitive Bias Affect Conversations With Patients About Dietary Supplements? Ila M. Harris, PharmD, Christine C. Danner, PhD, and David J. Satin, MD Some allopathic clinicians’ biases influence the information they draw upon to make decisions and offer recommendations. AMA J Ethics. 2022;24(5):E368-375. doi: 10.1001/amajethics.2022.368. Policy Forum May 2022 Which Features of Dietary Supplement Industry, Product Trends, and Regulation Deserve Physicians’ Attention? Amy B. Cadwallader, PhD and AMA Council on Science and Public Health Illegal, fraudulent, adulterated, or improperly labeled products should be regarded as sources of possible clinical and ethical harm to patients. AMA J Ethics. 2022;24(5):E410-418. doi: 10.1001/amajethics.2022.410. Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Page 3 Page 4 Current page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »
Letter to the Editor Jul 2020 Response to “A Deliberate Public Policy Plus Naivety at Best” Stella Aguinaga Bialous, DrPH and Yvette van der Eijk, PhD Debate continues on how to frame tobacco and nicotine product regulation from a children’s rights perspective. AMA J Ethics. 2020;22(7):E643-644. doi: 10.1001/amajethics.2020.643.
State of the Art and Science Apr 2016 Keeping the Backdoor to Eugenics Ajar?: Disability and the Future of Prenatal Screening Gareth M. Thomas, PhD and Barbara Katz Rothman, PhD Noninvasive prenatal testing arguably constitutes a form of eugenics in a social context in which certain reproductive outcomes are not valued. AMA J Ethics. 2016;18(4):406-415. doi: 10.1001/journalofethics.2016.18.4.stas1-1604.
Case and Commentary Feb 2022 ¿Cómo deben los médicos determinar la disposición de un paciente traumatizado para regresar al trabajo? Tabitha E. H. Moses, MS and Arash Javanbakht, MD AMA J Ethics. 2022;E111-119. doi: 10.1001/amajethics.2022.111.
Case and Commentary Feb 2022 ¿Debería un médico alguna vez violar los protocolos SWAT o TEMS durante un incidente con múltiples víctimas? Brandon Morshedi, MD, DPT and Faroukh Mehkri, DO AMA J Ethics. 2022;E120-125. doi: 10.1001/amajethics.2022.120.
Policy Forum Feb 2022 ¿Cómo deberían los clínicos tácticos ayudar a hacer un uso más justo de la fuerza? David Callaway, MD and Faroukh Mehkri, DO AMA J Ethics. 2022;E133-139. doi: 10.1001/amajethics.2022.133.
Policy Forum Feb 2022 ¿Cómo se debería equilibrar el riesgo para el personal táctico con los requerimientos clínicos y ética de rescate? Mollie V. Williams, MD, MPH and Olaitan Ajisafe, MD, PharmD AMA J Ethics. 2022;E140-144. doi: 10.1001/amajethics.2022.140.
Podcast Feb 2022 Author Interview: “How Should Clinicians Determine a Traumatized Patient’s Readiness to Return to Work?” Tabitha E. H. Moses, MS joins Ethics Talk to discuss her article, coauthored with Dr Arash Javanbakht: “How Should Clinicians Determine a Traumatized Patient’s Readiness to Return to Work?”
Case and Commentary May 2022 Should Clinicians Prescribe Non-FDA Regulated Dietary Supplements When Caring for Children With Hypovitaminosis D? Ethan A. Mezoff, MD, Hannah Hays, MD, and Ala Shaikhkhalil, MD Children with micronutrient deficiency might need supplementation, sometimes in irregularly high doses. AMA J Ethics. 2022;24(5):E353-360. doi: 10.1001/amajethics.2022.353.
Case and Commentary May 2022 How Does Cognitive Bias Affect Conversations With Patients About Dietary Supplements? Ila M. Harris, PharmD, Christine C. Danner, PhD, and David J. Satin, MD Some allopathic clinicians’ biases influence the information they draw upon to make decisions and offer recommendations. AMA J Ethics. 2022;24(5):E368-375. doi: 10.1001/amajethics.2022.368.
Policy Forum May 2022 Which Features of Dietary Supplement Industry, Product Trends, and Regulation Deserve Physicians’ Attention? Amy B. Cadwallader, PhD and AMA Council on Science and Public Health Illegal, fraudulent, adulterated, or improperly labeled products should be regarded as sources of possible clinical and ethical harm to patients. AMA J Ethics. 2022;24(5):E410-418. doi: 10.1001/amajethics.2022.410.